Brain study aims to unlock ketamine's fast-acting OCD relief
NCT ID NCT05940324
First seen May 04, 2026 · Last updated May 06, 2026 · Updated 1 time
Summary
This study looks at how ketamine works in the brain to quickly reduce symptoms of obsessive-compulsive disorder (OCD). Researchers will measure changes in OCD severity using a standard scale. The study involves 150 adults aged 18-65 with OCD who have not improved with at least one standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychiatry & Behavioral Sciences
RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.